A metabolic dependency of EBV can be targeted to hinder B cell transformation.
Müller-Durovic B, Jäger J, Engelmann C, Schuhmachers P, Altermatt S, Schlup Y, Duthaler U, Makowiec C, Unterstab G, Roffeis S, Xhafa E, Assmann N, Trulsson F, Steiner R, Edwards-Hicks J, West J, Turner L, Develioglu L, Ivanek R, Azzi T, Dehio P, Berger C; Swiss Transplant Cohort Study#; Kuzmin D, Saboz S, Mautner J, Löliger J, Geigges M, Palianina D, Khanna N, Dirnhofer S, Münz C, Bantug GR, Hess C, Berger C, Hess C, Koller M, Rossi S, Stampf S, Müller NJ.
Müller-Durovic B, et al. Among authors: muller nj.
Science. 2024 May 23:eadk4898. doi: 10.1126/science.adk4898. Online ahead of print.
Science. 2024.
PMID: 38781354